Hypoparathyroidism Treatment Market Size & Forecast 2025-35

Future Market Insights

Hypoparathyroidism Treatment Market

Key Insight

Hypoparathyroidism treatment sales will expand through 2035, with calcium supplements at 37.9% of the drug category and retail pharmacies at 37.1% of distribution channel demand in 2025. The market was valued at USD 785.7 million in 2025 and is forecast to record a 3.9% CAGR between 2025 and 2035.

June 13, 2025

Anurag Sharma

502 Pages

Cite this Report

Hypoparathyroidism Treatment Market

https://www.futuremarketinsights.com/reports/hypoparathyroidism-treatment-market

License

Buy Now

Summary ToC Companies

Key Players

Amgen
Ascendis Pharma A/S
BionPharma Inc
Entera Bio Ltd
Extend Biosciences
F. Hoffmann-La Roche Ag
ProLynx
Takeda Pharmaceuticals

Methodology

Member of

Greater New York Chamber of Commerce

Recognized by

Awarded by

SILVER STEVIE® WINNER

Asia Pacific Stevie Awards - 2023

BRONZE STEVIE® Award

20th annual IBAs

Quick Contact

Chat on Whatsapp + 44 20 3769 9709 + 1 347 918 3531 Contact By Email

Get Free Sample PDF

Hypoparathyroidism Treatment Market

Key Players

Similar Industry Reports